speb/financial-data huggingface dataset:
EYE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 248634000.00
EYE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1380000.00
EYE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 48891000.00
EYE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 8373000.00
EYE balance_sheet (quarterly, 2025-03-31) — Other Payable: 115070000.00
EYE balance_sheet (quarterly, 2025-03-31) — Other Properties: 760398000.00
EYE balance_sheet (quarterly, 2025-03-31) — Payables: 151731000.00
EYE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 151731000.00
EYE income_statement (quarterly, 2025-03-31) — Pretax Income: 21565000.00
EYE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -20225000.00
EYE balance_sheet (quarterly, 2025-03-31) — Raw Materials: 58226000.00
EYE balance_sheet (quarterly, 2025-03-31) — Receivables: 53169000.00
EYE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 203033000.00
EYE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 25120000.00
EYE cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -4045000.00
EYE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1624000.00
EYE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 240303000.00
EYE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 255532000.00
EYE balance_sheet (quarterly, 2025-03-31) — Share Issued: 85847214.00
EYE income_statement (quarterly, 2025-03-31) — Special Income Charges: -502000.00
EYE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 7029000.00
EYE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 836160000.00
EYE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -110779000.00
EYE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -171684.00
EYE income_statement (quarterly, 2025-03-31) — Tax Provision: 7379000.00
EYE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.34
EYE balance_sheet (quarterly, 2025-03-31) — Total Assets: 2010352000.00
EYE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1080812000.00
EYE balance_sheet (quarterly, 2025-03-31) — Total Debt: 805113000.00
EYE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 836160000.00
EYE income_statement (quarterly, 2025-03-31) — Total Expenses: 483685000.00
EYE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1174192000.00
EYE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1756228000.00
EYE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 705983000.00
EYE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 26137000.00
EYE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -502000.00
EYE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -502000.00
EYE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 6797000.00
EYE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 219310000.00
EYE balance_sheet (quarterly, 2025-03-31) — Working Capital: -214085000.00
EYE income_statement (quarterly, 2025-06-30) — +Operating Expense: 269603000.00
EYE income_statement (quarterly, 2025-06-30) — +Total Revenue: 486423000.00
EYE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 65099000.00
EYE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 45958000.00
EYE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 820059000.00
EYE balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -200000.00
EYE cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
EYE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 79079000.00
EYE income_statement (quarterly, 2025-06-30) — Basic EPS: 0.11
EYE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 81847000.00
EYE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -11850000.00
EYE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 446940000.00
EYE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 859000.00
EYE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 48471000.00
EYE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 48471000.00
EYE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -73421000.00
EYE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -12699000.00
EYE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 54261000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 28438000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Inventory: -1840000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -15893000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 7711000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -7100000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Payable: 28438000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 28438000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Receivables: 6970000.00
EYE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 18286000.00
EYE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 6970000.00
EYE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -31859000.00
EYE balance_sheet (quarterly, 2025-06-30) — Common Stock: 859000.00
EYE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 850581000.00
EYE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 471000.00
EYE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -55000.00
EYE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 200371000.00
EYE balance_sheet (quarterly, 2025-06-30) — Current Assets: 217701000.00
EYE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 102213000.00
EYE balance_sheet (quarterly, 2025-06-30) — Current Debt: 16782000.00
EYE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 118995000.00
EYE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 107422000.00
EYE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 107422000.00
EYE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 418246000.00
EYE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -4017000.00
EYE cash_flow (quarterly, 2025-06-30) — Deferred Tax: -4017000.00
EYE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 20379000.00
EYE income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 22536000.00
EYE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 20379000.00
EYE income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 22536000.00
EYE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 80057000.00
EYE income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.11
EYE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 8725000.00
EYE income_statement (quarterly, 2025-06-30) — EBIT: 16449000.00
EYE income_statement (quarterly, 2025-06-30) — EBITDA: 38985000.00
EYE cash_flow (quarterly, 2025-06-30) — End Cash Position: 49988000.00
EYE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -73421000.00
EYE balance_sheet (quarterly, 2025-06-30) — Finished Goods: 28284000.00
EYE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 42411000.00
EYE balance_sheet (quarterly, 2025-06-30) — Goodwill: 698305000.00
EYE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 946757000.00
EYE balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 46158000.00
EYE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 742435000.00
EYE income_statement (quarterly, 2025-06-30) — Gross Profit: 286052000.00
EYE income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
EYE income_statement (quarterly, 2025-06-30) — Interest Expense: 4210000.00
EYE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4210000.00
EYE cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 5602000.00
EYE balance_sheet (quarterly, 2025-06-30) — Inventory: 89648000.00
EYE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1122983000.00
EYE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -12699000.00
EYE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 471000.00
EYE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 344727000.00
EYE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 255620000.00
EYE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 600347000.00
EYE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -88837000.00
EYE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 416000.00
EYE balance_sheet (quarterly, 2025-06-30) — Net Debt: 223931000.00
EYE income_statement (quarterly, 2025-06-30) — Net Income: 8725000.00
EYE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 8725000.00
EYE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 8725000.00
EYE income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
EYE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 8725000.00
EYE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 8725000.00
EYE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 8725000.00
EYE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 8725000.00
EYE income_statement (quarterly, 2025-06-30) — Net Interest Income: -4210000.00
EYE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -73837000.00
EYE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -73837000.00
EYE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4210000.00
EYE balance_sheet (quarterly, 2025-06-30) — Net PPE: 742435000.00
EYE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -11850000.00
EYE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -96176000.00
EYE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 90887000.00
EYE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 22778000.00
EYE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 68109000.00
EYE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 38985000.00
EYE income_statement (quarterly, 2025-06-30) — Normalized Income: 8725000.00
EYE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 54261000.00
EYE income_statement (quarterly, 2025-06-30) — Operating Income: 16449000.00
EYE income_statement (quarterly, 2025-06-30) — Operating Revenue: 486423000.00
EYE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 79175000.00
EYE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 33624000.00
EYE balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 16782000.00
EYE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 248452000.00
EYE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 5582000.00
EYE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 61459000.00
EYE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 8291000.00
EYE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -100000.00
EYE balance_sheet (quarterly, 2025-06-30) — Other Payable: 126730000.00
EYE balance_sheet (quarterly, 2025-06-30) — Other Properties: 742435000.00
EYE balance_sheet (quarterly, 2025-06-30) — Payables: 191829000.00
EYE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 191829000.00
EYE income_statement (quarterly, 2025-06-30) — Pretax Income: 12239000.00
EYE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -11850000.00
EYE balance_sheet (quarterly, 2025-06-30) — Raw Materials: 61364000.00
EYE balance_sheet (quarterly, 2025-06-30) — Receivables: 45958000.00
EYE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 202528000.00
EYE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 20379000.00
EYE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -88837000.00
EYE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -55000.00
EYE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 249028000.00
EYE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 247167000.00
EYE balance_sheet (quarterly, 2025-06-30) — Share Issued: 85977000.00
EYE income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
EYE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5306000.00
EYE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 850581000.00
EYE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -96176000.00
EYE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
EYE income_statement (quarterly, 2025-06-30) — Tax Provision: 3514000.00
EYE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.29
EYE balance_sheet (quarterly, 2025-06-30) — Total Assets: 1968352000.00
EYE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1106201000.00
EYE balance_sheet (quarterly, 2025-06-30) — Total Debt: 719342000.00
EYE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 850581000.00
EYE income_statement (quarterly, 2025-06-30) — Total Expenses: 469974000.00
EYE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1117771000.00
EYE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1750651000.00
EYE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 699525000.00
EYE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 16449000.00
EYE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
EYE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
EYE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 6802000.00
EYE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 219365000.00
EYE balance_sheet (quarterly, 2025-06-30) — Working Capital: -200545000.00
EYE income_statement (quarterly, 2025-09-30) — +Operating Expense: 274523000.00
EYE income_statement (quarterly, 2025-09-30) — +Total Revenue: 487330000.00
EYE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 74264000.00
EYE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 46134000.00
EYE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 825742000.00
EYE balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -600000.00
EYE cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
EYE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 79223000.00
EYE income_statement (quarterly, 2025-09-30) — Basic EPS: 0.04
EYE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 49988000.00
EYE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -16366000.00
EYE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 440202000.00
EYE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 860000.00
EYE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 56030000.00
EYE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 56030000.00
EYE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -19684000.00
EYE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -19365000.00
EYE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 46634000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 9165000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Inventory: -381000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 738000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -9434000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 2945000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Payable: 9165000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 9165000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -655000.00
EYE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2378000.00
EYE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -655000.00
EYE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7585000.00
EYE balance_sheet (quarterly, 2025-09-30) — Common Stock: 860000.00
EYE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 858761000.00
EYE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 277000.00
EYE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -876000.00
EYE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 203199000.00
EYE balance_sheet (quarterly, 2025-09-30) — Current Assets: 220188000.00
EYE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 102378000.00
EYE balance_sheet (quarterly, 2025-09-30) — Current Debt: 16852000.00
EYE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 119230000.00
EYE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 111329000.00
EYE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 111329000.00
EYE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 416965000.00
EYE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 8921000.00
EYE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 8921000.00
EYE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 22185000.00
EYE income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 22185000.00
EYE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 22185000.00
EYE income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 22185000.00
EYE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 81195000.00
EYE income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.04
EYE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 3372000.00
EYE income_statement (quarterly, 2025-09-30) — EBIT: 9608000.00
EYE income_statement (quarterly, 2025-09-30) — EBITDA: 31793000.00
EYE cash_flow (quarterly, 2025-09-30) — End Cash Position: 57573000.00
EYE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -19684000.00
EYE balance_sheet (quarterly, 2025-09-30) — Finished Goods: 25156000.00
EYE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 30268000.00
EYE balance_sheet (quarterly, 2025-09-30) — Goodwill: 700642000.00
EYE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 948913000.00
EYE balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 46734000.00
EYE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 726928000.00
EYE income_statement (quarterly, 2025-09-30) — Gross Profit: 284131000.00
EYE income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
EYE cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 694000.00
EYE income_statement (quarterly, 2025-09-30) — Interest Expense: 4119000.00
EYE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 4119000.00
EYE cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 4478000.00
EYE balance_sheet (quarterly, 2025-09-30) — Inventory: 88012000.00
EYE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1112127000.00
EYE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -19365000.00
EYE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 277000.00
EYE cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: -15000000.00
EYE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 337824000.00
EYE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 236514000.00
EYE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 574338000.00
EYE cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: -15000000.00
EYE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -4085000.00
EYE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -599000.00
EYE balance_sheet (quarterly, 2025-09-30) — Net Debt: 197336000.00
EYE income_statement (quarterly, 2025-09-30) — Net Income: 3372000.00
EYE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 3372000.00
EYE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 3372000.00
EYE income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
EYE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 3372000.00
EYE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 3372000.00
EYE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 3372000.00
EYE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 3372000.00
EYE income_statement (quarterly, 2025-09-30) — Net Interest Income: -4119000.00
EYE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -19085000.00
EYE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -19085000.00
EYE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4119000.00
EYE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -2999000.00
EYE balance_sheet (quarterly, 2025-09-30) — Net PPE: 726928000.00
EYE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -16366000.00
EYE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -90152000.00
EYE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 99978000.00
EYE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 22948000.00
EYE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 77030000.00
EYE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 31793000.00
EYE income_statement (quarterly, 2025-09-30) — Normalized Income: 3372000.00
EYE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 46634000.00
EYE income_statement (quarterly, 2025-09-30) — Operating Income: 9608000.00
EYE income_statement (quarterly, 2025-09-30) — Operating Revenue: 487330000.00
EYE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 79259590.00
EYE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 30012000.00
EYE balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 16852000.00
EYE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 248271000.00
EYE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 4277000.00
EYE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 62443000.00
EYE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 8430000.00
EYE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -1000.00
EYE balance_sheet (quarterly, 2025-09-30) — Other Payable: 112142000.00
EYE balance_sheet (quarterly, 2025-09-30) — Other Properties: 726928000.00
EYE balance_sheet (quarterly, 2025-09-30) — Payables: 186406000.00
EYE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 186406000.00
EYE income_statement (quarterly, 2025-09-30) — Pretax Income: 5489000.00
EYE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -16366000.00
EYE balance_sheet (quarterly, 2025-09-30) — Raw Materials: 62856000.00
EYE balance_sheet (quarterly, 2025-09-30) — Receivables: 46134000.00
EYE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 203199000.00
EYE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 22185000.00
EYE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -4085000.00
EYE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -876000.00
EYE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 252400000.00
EYE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 252339000.00
EYE balance_sheet (quarterly, 2025-09-30) — Share Issued: 86098306.00
EYE income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
EYE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5501000.00
EYE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 858761000.00
EYE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -90152000.00
EYE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
EYE income_statement (quarterly, 2025-09-30) — Tax Provision: 2117000.00
EYE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.39
EYE balance_sheet (quarterly, 2025-09-30) — Total Assets: 1958472000.00
EYE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1095275000.00
EYE balance_sheet (quarterly, 2025-09-30) — Total Debt: 693568000.00
EYE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 858761000.00
EYE income_statement (quarterly, 2025-09-30) — Total Expenses: 477722000.00
EYE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1099711000.00
EYE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1738284000.00
EYE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 682746000.00
EYE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 9608000.00
EYE income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
EYE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
EYE balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 6838716.00
EYE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 220241000.00
EYE balance_sheet (quarterly, 2025-09-30) — Working Capital: -196777000.00
EYE income_statement (annual, 2025-12-31) — +Operating Expense: 1107199000.00
EYE income_statement (quarterly, 2025-12-31) — +Operating Expense: 284578000.00
EYE income_statement (annual, 2025-12-31) — +Total Revenue: 1987488000.00
EYE income_statement (quarterly, 2025-12-31) — +Total Revenue: 503411000.00
EYE balance_sheet (annual, 2025-12-31) — Accounts Payable: 78999000.00
EYE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 78999000.00
EYE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 42563000.00
EYE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 42563000.00
EYE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -643415000.00
EYE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -643415000.00
EYE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 834000000.00
EYE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 834000000.00
EYE cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 8741000.00
EYE cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 8741000.00
EYE cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 1991000.00
EYE cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1489000.00
EYE income_statement (annual, 2025-12-31) — Basic Average Shares: 79131000.00
EYE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 79347000.00
EYE income_statement (annual, 2025-12-31) — Basic EPS: 0.37
EYE income_statement (quarterly, 2025-12-31) — Basic EPS: 0.04
EYE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 75237000.00
EYE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 57573000.00
EYE cash_flow (annual, 2025-12-31) — Capital Expenditure: -72840000.00
EYE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -24399000.00
EYE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 458112000.00
EYE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 458112000.00
EYE balance_sheet (annual, 2025-12-31) — Capital Stock: 862000.00
EYE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 862000.00
EYE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 38708000.00
EYE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 38708000.00
EYE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 38708000.00
EYE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 38708000.00
EYE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -104622000.00
EYE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -6113000.00
EYE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -76606000.00
EYE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -24317000.00
EYE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 146293000.00
EYE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 13159000.00
EYE cash_flow (annual, 2025-12-31) — Change In Account Payable: 25356000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 4735000.00
EYE cash_flow (annual, 2025-12-31) — Change In Inventory: -728000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Inventory: -2816000.00
EYE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -45656000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -19579000.00
EYE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1875000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -7301000.00
EYE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 10944000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 5507000.00
EYE cash_flow (annual, 2025-12-31) — Change In Payable: 25356000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Payable: 4735000.00
EYE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 25356000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 4735000.00
EYE cash_flow (annual, 2025-12-31) — Change In Receivables: -8069000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -11043000.00
EYE cash_flow (annual, 2025-12-31) — Change In Working Capital: -20028000.00
EYE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -30497000.00
EYE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -8069000.00
EYE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -11043000.00
EYE cash_flow (annual, 2025-12-31) — Changes In Cash: -34935000.00
EYE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -17271000.00
EYE balance_sheet (annual, 2025-12-31) — Common Stock: 862000.00
EYE balance_sheet (quarterly, 2025-12-31) — Common Stock: 862000.00
EYE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 869533000.00
EYE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 869533000.00
EYE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3395000.00
EYE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 2382000.00
EYE cash_flow (annual, 2025-12-31) — Common Stock Payments: -3205000.00
EYE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -650000.00
EYE balance_sheet (annual, 2025-12-31) — Construction In Progress: 34711000.00
EYE balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 34711000.00
EYE income_statement (annual, 2025-12-31) — Cost Of Revenue: 819469000.00
EYE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 210709000.00
EYE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 46214000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 46214000.00
EYE balance_sheet (annual, 2025-12-31) — Current Assets: 225722000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Assets: 225722000.00
EYE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 93646000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 93646000.00
EYE balance_sheet (annual, 2025-12-31) — Current Debt: 13250000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Debt: 13250000.00
EYE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 106896000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 106896000.00
EYE balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 116839000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 116839000.00
EYE balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 116839000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 116839000.00
EYE balance_sheet (annual, 2025-12-31) — Current Liabilities: 412408000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 412408000.00
EYE balance_sheet (annual, 2025-12-31) — Current Provisions: 5489000.00
EYE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 5489000.00
EYE cash_flow (annual, 2025-12-31) — Deferred Income Tax: 4663000.00
EYE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 5542000.00
EYE cash_flow (annual, 2025-12-31) — Deferred Tax: 4663000.00
EYE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 5542000.00
EYE cash_flow (annual, 2025-12-31) — Depreciation: 91152000.00
EYE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 99893000.00
EYE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 32209000.00
EYE income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 91152000.00
EYE income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 23468000.00
EYE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 99893000.00
EYE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 32209000.00
EYE income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 91152000.00
EYE income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 23468000.00
EYE income_statement (annual, 2025-12-31) — Diluted Average Shares: 80576000.00
EYE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 81777000.00
EYE income_statement (annual, 2025-12-31) — Diluted EPS: 0.37
EYE income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.04
EYE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 29600000.00
EYE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3317000.00
EYE income_statement (annual, 2025-12-31) — EBIT: 58829000.00
EYE income_statement (quarterly, 2025-12-31) — EBIT: 6635000.00
EYE income_statement (annual, 2025-12-31) — EBITDA: 158722000.00
EYE income_statement (quarterly, 2025-12-31) — EBITDA: 38844000.00
EYE cash_flow (annual, 2025-12-31) — End Cash Position: 40302000.00
EYE cash_flow (quarterly, 2025-12-31) — End Cash Position: 40302000.00
EYE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -104622000.00
EYE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -6113000.00
EYE balance_sheet (annual, 2025-12-31) — Finished Goods: 23543000.00
EYE balance_sheet (quarterly, 2025-12-31) — Finished Goods: 23543000.00
EYE cash_flow (annual, 2025-12-31) — Free Cash Flow: 73453000.00
EYE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -11240000.00
EYE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -121000.00
EYE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -121000.00
EYE balance_sheet (annual, 2025-12-31) — Goodwill: 700642000.00
EYE balance_sheet (quarterly, 2025-12-31) — Goodwill: 700642000.00
EYE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 948743000.00
EYE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 948743000.00
EYE balance_sheet (annual, 2025-12-31) — Gross PPE: 1382930000.00
EYE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1382930000.00
EYE income_statement (annual, 2025-12-31) — Gross Profit: 1168019000.00
EYE income_statement (quarterly, 2025-12-31) — Gross Profit: 292702000.00
EYE income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 1991000.00
EYE income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 1489000.00
EYE cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 21146000.00
EYE cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 3488000.00
EYE balance_sheet (annual, 2025-12-31) — Income Tax Payable: 556000.00
EYE balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 556000.00
EYE income_statement (annual, 2025-12-31) — Interest Expense: 17148000.00
EYE income_statement (quarterly, 2025-12-31) — Interest Expense: 4247000.00
EYE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 17148000.00
EYE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 4247000.00
EYE cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 19091000.00
EYE cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 4462000.00
EYE balance_sheet (annual, 2025-12-31) — Inventory: 89318000.00
EYE balance_sheet (quarterly, 2025-12-31) — Inventory: 89318000.00
EYE balance_sheet (annual, 2025-12-31) — Invested Capital: 1106021000.00
EYE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1106021000.00
EYE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -76606000.00
EYE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -24317000.00
EYE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3395000.00
EYE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 2382000.00
EYE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 25000000.00
EYE cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 25000000.00
EYE balance_sheet (annual, 2025-12-31) — Land And Improvements: 3736000.00
EYE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 3736000.00
EYE balance_sheet (annual, 2025-12-31) — Leases: 386329000.00
EYE balance_sheet (quarterly, 2025-12-31) — Leases: 386329000.00
EYE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 364466000.00
EYE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 364466000.00
EYE balance_sheet (annual, 2025-12-31) — Long Term Debt: 223238000.00
EYE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 223238000.00
EYE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 587704000.00
EYE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 587704000.00
EYE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 25000000.00
EYE cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 25000000.00
EYE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -129812000.00
EYE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -32845000.00
EYE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 211808000.00
EYE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 211808000.00
EYE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 190000.00
EYE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1732000.00
EYE balance_sheet (annual, 2025-12-31) — Net Debt: 197780000.00
EYE balance_sheet (quarterly, 2025-12-31) — Net Debt: 197780000.00
EYE income_statement (annual, 2025-12-31) — Net Income: 29600000.00
EYE income_statement (quarterly, 2025-12-31) — Net Income: 3317000.00
EYE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 29600000.00
EYE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3317000.00
EYE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 29600000.00
EYE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3317000.00
EYE income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
EYE income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
EYE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 29600000.00
EYE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3317000.00
EYE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 29600000.00
EYE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3317000.00
EYE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 29600000.00
EYE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 3317000.00
EYE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 29600000.00
EYE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3317000.00
EYE income_statement (annual, 2025-12-31) — Net Interest Income: -17148000.00
EYE income_statement (quarterly, 2025-12-31) — Net Interest Income: -4247000.00
EYE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -104812000.00
EYE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -7845000.00
EYE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -104812000.00
EYE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -7845000.00
EYE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -17148000.00
EYE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -4247000.00
EYE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -3766000.00
EYE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 82000.00
EYE balance_sheet (annual, 2025-12-31) — Net PPE: 739515000.00
EYE balance_sheet (quarterly, 2025-12-31) — Net PPE: 739515000.00
EYE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -72840000.00
EYE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -24399000.00
EYE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -79210000.00
EYE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -79210000.00
EYE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 105089000.00
EYE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 105089000.00
EYE balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 22517000.00
EYE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 22517000.00
EYE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 82572000.00
EYE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 82572000.00
EYE income_statement (annual, 2025-12-31) — Normalized EBITDA: 160713000.00
EYE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 40333000.00
EYE income_statement (annual, 2025-12-31) — Normalized Income: 31013610.00
EYE income_statement (quarterly, 2025-12-31) — Normalized Income: 4210400.00
EYE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 146293000.00
EYE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 13159000.00
EYE income_statement (annual, 2025-12-31) — Operating Income: 60820000.00
EYE income_statement (quarterly, 2025-12-31) — Operating Income: 8124000.00
EYE income_statement (annual, 2025-12-31) — Operating Revenue: 1987488000.00
EYE income_statement (quarterly, 2025-12-31) — Operating Revenue: 503411000.00
EYE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 79416050.00
EYE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 79416050.00
EYE balance_sheet (annual, 2025-12-31) — Other Current Assets: 40374000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 40374000.00
EYE balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 13250000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 13250000.00
EYE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -121000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -121000.00
EYE income_statement (annual, 2025-12-31) — Other Income Expense: -1991000.00
EYE income_statement (quarterly, 2025-12-31) — Other Income Expense: -1489000.00
EYE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 248101000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 248101000.00
EYE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 6488000.00
EYE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -4751000.00
EYE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 69698000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 69698000.00
EYE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 8944000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 8944000.00
EYE income_statement (annual, 2025-12-31) — Other Operating Expenses: -204000.00
EYE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -103000.00
EYE balance_sheet (annual, 2025-12-31) — Other Payable: 9696000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Payable: 9696000.00
EYE balance_sheet (annual, 2025-12-31) — Other Properties: 746346000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Properties: 746346000.00
EYE balance_sheet (annual, 2025-12-31) — Other Receivables: 15047000.00
EYE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 15047000.00
EYE balance_sheet (annual, 2025-12-31) — Payables: 89251000.00
EYE balance_sheet (quarterly, 2025-12-31) — Payables: 89251000.00
EYE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 135465000.00
EYE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 135465000.00
EYE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 47719000.00
EYE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 47719000.00
EYE income_statement (annual, 2025-12-31) — Pretax Income: 41681000.00
EYE income_statement (quarterly, 2025-12-31) — Pretax Income: 2388000.00
EYE balance_sheet (annual, 2025-12-31) — Properties: 0.00
EYE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
EYE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -72840000.00
EYE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -24399000.00
EYE balance_sheet (annual, 2025-12-31) — Raw Materials: 65775000.00
EYE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 65775000.00
EYE balance_sheet (annual, 2025-12-31) — Receivables: 57322000.00
EYE balance_sheet (quarterly, 2025-12-31) — Receivables: 57322000.00
EYE balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -288000.00
EYE balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -288000.00
EYE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 810728000.00
EYE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 201968000.00
EYE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 99893000.00
EYE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 32209000.00
EYE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -129812000.00
EYE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -32845000.00
EYE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -3205000.00
EYE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -650000.00
EYE balance_sheet (annual, 2025-12-31) — Retained Earnings: 255717000.00
EYE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 255717000.00
EYE income_statement (annual, 2025-12-31) — Selling General And Administration: 1016251000.00
EYE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 261213000.00
EYE balance_sheet (annual, 2025-12-31) — Share Issued: 86278538.00
EYE balance_sheet (quarterly, 2025-12-31) — Share Issued: 86278538.00
EYE income_statement (annual, 2025-12-31) — Special Income Charges: -1991000.00
EYE income_statement (quarterly, 2025-12-31) — Special Income Charges: -1489000.00
EYE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 23686000.00